FIELD: medicine.
SUBSTANCE: invention relates to field of medicine. In order to diagnose metabolic syndrome it is found out if abdominal obesity, arterial hypertension, hyperglycemia on the empty stomach, hypertriglyceridemia, hypoalphacholesterinemia, hyperuricemia, non-alcohol fatty liver disease are present. Additionally determined is excessive body weight or obesity independent on type of fat deposition, insulin-resistance, hypercholesterinemia. Degree of each component expression is determined in points. Metabolic syndrome, its degree of severity and degree of risk of development are diagnosed by the sum of points, as well as by presence of necessary set of components.
EFFECT: method makes it possible to diagnose metabolic syndrome, degree of risk and degree of severity of its development.
14 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD OF PERSONIFIED PREDICTION OF CLINICAL EFFECTIVENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME | 2020 |
|
RU2737503C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING METABOLIC SYNDROME IN YOUNG MALES AGED 18-44 YEARS WHO WORK AT NIGHT | 2021 |
|
RU2778003C1 |
| DIAGNOSTIC TECHNIQUE FOR METABOLIC SYNDROME IN CHILDREN | 2013 |
|
RU2527847C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD OF DIAGNOSTICS OF METABOLIC SYNDROME BY ULTRASONIC LIPOMETRY | 2017 |
|
RU2677526C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF INSULIN RESISTANCE | 2019 |
|
RU2748034C2 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
